211 related articles for article (PubMed ID: 17947677)
1. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
Truffinet V; Pinaud E; Cogné N; Petit B; Guglielmi L; Cogné M; Denizot Y
J Immunol; 2007 Nov; 179(9):6033-42. PubMed ID: 17947677
[TBL] [Abstract][Full Text] [Related]
2. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
3. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
4. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
5. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
[TBL] [Abstract][Full Text] [Related]
7. Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas.
Ghazzaui N; Issaoui H; Ferrad M; Carrion C; Cook-Moreau J; Denizot Y; Boyer F
Blood Adv; 2020 Jan; 4(1):28-39. PubMed ID: 31899800
[TBL] [Abstract][Full Text] [Related]
8. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
Fiancette R; Amin R; Truffinet V; Vincent-Fabert C; Cogné N; Cogné M; Denizot Y
Leuk Res; 2010 Aug; 34(8):1043-51. PubMed ID: 20018375
[TBL] [Abstract][Full Text] [Related]
9. Burkitt lymphoma in the mouse.
Kovalchuk AL; Qi CF; Torrey TA; Taddesse-Heath L; Feigenbaum L; Park SS; Gerbitz A; Klobeck G; Hoertnagel K; Polack A; Bornkamm GW; Janz S; Morse HC
J Exp Med; 2000 Oct; 192(8):1183-90. PubMed ID: 11034608
[TBL] [Abstract][Full Text] [Related]
10. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
[TBL] [Abstract][Full Text] [Related]
11. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
12. The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis.
Ghazzaui N; Saintamand A; Issaoui H; Vincent-Fabert C; Denizot Y
Oncotarget; 2017 Jan; 8(4):7059-7067. PubMed ID: 27729620
[TBL] [Abstract][Full Text] [Related]
13. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
[TBL] [Abstract][Full Text] [Related]
14. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
16. Developmental propagation of V(D)J recombination-associated DNA breaks and translocations in mature B cells via dicentric chromosomes.
Hu J; Tepsuporn S; Meyers RM; Gostissa M; Alt FW
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10269-74. PubMed ID: 24982162
[TBL] [Abstract][Full Text] [Related]
17. Forward and reverse changes in Ig/myc translocation carrying tumors.
Klein G
Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
[TBL] [Abstract][Full Text] [Related]
18. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma.
Neri A; Barriga F; Knowles DM; Magrath IT; Dalla-Favera R
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2748-52. PubMed ID: 2833750
[TBL] [Abstract][Full Text] [Related]
19. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
20. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]